郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价A novel method for analyzing extremely biased agonism at G protein-coupled receptors.

期刊：Molecular pharmacology发表年份：2015作者：Edward L Stahl; Lei Zhou; Frederick J Ehlert; Laura M Bohn
阅读更多 →

药效评价Activation of peripheral KCNQ channels relieves gout pain.

期刊：Pain发表年份：2015作者：Yueming Zheng; Haiyan Xu; Li Zhan; Xindi Zhou; Xueqin Chen; Zhaobing Gao
阅读更多 →

药效评价Structure-activity relationship studies of functionally selective kappa opioid receptor agonists that modulate ERK 1/2 phosphorylation while preserving G protein over βarrestin2 signaling bias.

期刊：ACS chemical neuroscience发表年份：2015作者：Kimberly M Lovell; Kevin J Frankowski; Edward L Stahl; Stephen R Slauson; Euna Yoo; Thomas E Prisinzano; Jeffrey Aubé; Laura M Bohn
阅读更多 →

药效评价3D-QSAR Based Pharmacophore Modeling and Virtual Screening for Identification of Novel G Protein-Coupled Receptor40 Agonists.

期刊：Current computer-aided drug design发表年份：2015作者：Peng Lu; Yubin Wang; PingKai Ouyang; Jinxiong She; Mingfang He
阅读更多 →